Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
1. Abbott's Q4 sales rose 7.2% but missed expectations. 2. Medical Device sales grew 13.7%, led by FreeStyle Libre. 3. Diabetes Care sales increased 22.7%, driven by glucose monitors. 4. Abbott expects 2025 EPS of $5.05-$5.25, slightly below consensus. 5. COVID-19 testing sales dropped significantly compared to last year.